Skip to main content
TipRanks
Go Ultimate75% OFF

PT Kalbe Farma Tbk (PTKFY) Stock Price & Analysis

7 Followers

PTKFY Stock Chart & Stats

$8.66$0.17(1.97%)
At close: 4:00 PM EST
$8$8.5$9Jul 28Aug 10Aug 17Oct 9
Day’s Range
$8.66 - $8.66
52-Week Range
$7.26 - $15.07
Previous Close
$8.49
Volume
N/A
Average Volume (3M)
510
Market Cap
$2.03B
Enterprise Value
$1.63B
Total Cash (Recent Filing)
$5.58T
Total Debt (Recent Filing)
$295.23B
Price to Earnings (P/E)
9.5
Beta
0.60
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
2.31%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage gives Kalbe Farma substantial financial flexibility and limits balance-sheet risk. Combined with consistently healthy returns on equity, this indicates the company generates attractive profits from its capital base without relying heavily on debt, supporting resilience and future investment capacity.

Steady Revenue And Earnings Base

Multi-year revenue expansion and continued positive profitability demonstrate a durable operating base across Kalbe Farma’s healthcare activities. Although growth has moderated, ongoing sales progression and a solid net margin provide recurring earnings support and a foundation for continued business development.

Diversified Healthcare Portfolio

Kalbe Farma’s presence across prescription and over-the-counter medicines, consumer health, nutrition, devices, and distribution diversifies its sources of demand. This broad healthcare platform can support business durability by reducing dependence on a single product category or customer need over time.

Bears Say

Margin Compression

The decline in gross and net margins from 2021–2022 levels signals pressure on profitability quality even though earnings remain solid. If this trend persists, it could limit operating leverage, reduce the benefit of revenue growth, and constrain the pace at which profits compound.

Moderating Growth

A slower recent growth trajectory reduces the near-term expansion rate of Kalbe Farma’s revenue and earnings base. Continued moderation would make it harder to absorb fixed costs, sustain prior profitability levels, or generate the same improvement in shareholder returns achieved during stronger growth periods.

Uneven Cash Conversion

Positive free cash flow supports the business, but volatility and weaker recent operating cash flow indicate that reported profits are not converting consistently into cash. Working-capital or timing effects could therefore make internally funded investment and shareholder distributions less predictable across periods.

PTKFY FAQ

What was PT Kalbe Farma Tbk’s price range in the past 12 months?
PT Kalbe Farma Tbk lowest stock price was $7.26 and its highest was $15.07 in the past 12 months.
What is PT Kalbe Farma Tbk’s market cap?
PT Kalbe Farma Tbk’s market cap is $2.03B.
When is PT Kalbe Farma Tbk’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PT Kalbe Farma Tbk’s earnings last quarter?
PT Kalbe Farma Tbk released its earnings results on Oct 30, 2026. The company reported $0.203 earnings per share for the quarter.
Is PT Kalbe Farma Tbk overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PT Kalbe Farma Tbk pay dividends?
PT Kalbe Farma Tbk pays an annual dividend of $0.223 which represents an annual dividend yield of 2.31%. See more information on PT Kalbe Farma Tbk dividends here
What is PT Kalbe Farma Tbk’s EPS estimate?
PT Kalbe Farma Tbk’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT Kalbe Farma Tbk have?
PT Kalbe Farma Tbk has 234,066,960 shares outstanding.
What happened to PT Kalbe Farma Tbk’s price movement after its last earnings report?
PT Kalbe Farma Tbk reported an EPS of $0.203 in its last earnings report. Following the earnings report the stock price went up 2.117%.
Which hedge fund is a major shareholder of PT Kalbe Farma Tbk?
Currently, no hedge funds are holding shares in PTKFY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology